Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.94
+0.45 (1.58%)
At close: Feb 27, 2026, 4:00 PM EST
29.00
+0.06 (0.21%)
After-hours: Feb 27, 2026, 7:42 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $20.71 billion as of February 27, 2026. Its market cap has increased by 178.04% in one year.
Market Cap
20.71B
Enterprise Value
16.29B
1-Year Change
178.04%
Ranking
Category
Stock Price
$28.94
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $20.71B, an increase of 3,783.26%. That is a compound annual growth rate of 101.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 20.71B | 37.24% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insmed | 32.19B |
| BioNTech SE | 27.72B |
| Royalty Pharma | 26.66B |
| Moderna | 21.16B |
| Incyte | 20.15B |
| Revolution Medicines | 20.10B |
| Genmab | 18.00B |
| Ascendis Pharma | 14.33B |